Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study

Vergote, Ignace; Van Nieuwenhuysen, Els; O'Cearbhaill, Roisin E.; Westermann, Anneke; Lorusso, Domenica; Ghamande, Sharad; Collins, Dearbhaile C.; Banerjee, Susana; Mathews, Cara A.; Gennigens, Christine; Cibula, David; Tewari, Krishnansu S.; Madsen, Kristine; Köse, Fatih; Jackson, Amanda L.; Boere, Ingrid A.; Scambia, Giovanni; Randall, Leslie M.; Sadozye, Azmat; Baurain, Jean-François; Gort, Eelke; Zikán, Michal; Denys, Hannelore G.; Ottevanger, Nelleke; Forget, Frédéric; Mondrup Andreassen, Camilla; Eaton, Lamar; Chisamore, Michael J.; Viana Nicacio, Leonardo; Soumaoro, Ibrahima; Monk, Bradley J.